Mike Fraser

Mike Fraser

Company: Novartis Gene Therapies

Job title: General Manager Europe, Middle East and Africa


Leveraging Knowledge from an Approved Gene Therapy Program in Europe: Key Learnings 9:00 am

Understanding the steps needed to deliver a comprehensive package to payors for early access Post-approval, what are the next steps to gain market access, and when’s the right time to prepare? Discussing frameworks that must be in place to ensure sustainable patient accessRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.